Home » Topics » BioWorld Science

BioWorld Science
RSS

European researchers identify CaSR-targeting antibodies

June 22, 2021

Lunan Pharmaceutical Group describes oleanane cinnamamide derivatives

June 22, 2021

New GTPase KRAS mutant inhibitors presented by Taiho Pharmaceutical

June 22, 2021

Medshine Discovery discloses Chk1 inhibitors for pancreatic cancer

June 22, 2021

BioNTech initiates first-in-human study of BNT-152 and BNT-153 in solid tumors

June 22, 2021

Origo Biopharma patents TGFBR1 inhibitors

June 22, 2021

First-in-human study of ChAdOx1 RVF vaccine candidate begins at University of Oxford

June 22, 2021

Enrollment opens in phase I study of DCC-3116 in advanced solid tumors with RAS or RAF mutations

June 22, 2021

First subject enrolled in OLYMPIA phase II study of OC-01

June 21, 2021

SIGMAR1 mRNA identified as biomarker of response in phase II study of blarcamesine

June 21, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...